Off-label use of the Sapien and Sapien XT valves represents a “viable and durable option” for restoring pulmonary valve function in patients with right-ventricular outflow tract (RVOT) disorders, ...
DUBLIN, May 15, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced results from two late-breaking clinical trials presented virtually at the 2020 Society for Cardiovascular Angiography ...
For years, innovations in the treatment of pulmonary valve regurgitation have relied on invasive surgical treatments—until now. A device from Medtronic that takes a minimally invasive approach to ...
Most patients who undergo percutaneous pulmonary valve implantation for right ventricular outflow tract (RVOT) dysfunction achieve acute hemodynamic benefit within 1 month that is sustained out to at ...
Grocery shopping, doing laundry, going up the stairs, showering—it’s these minuscule, mundane activities that, without us giving them much thought, make up most of our days. That thoughtlessness is ...
Biventricular correction of tetralogy of Fallot was devised more than 50 years ago. Current short-term outcomes are excellent. The potential for late complications is, however, an important concern ...
Ten-year outcomes from the Melody Transcatheter Pulmonary Valve (TPV) Therapy demonstrated strong long-term hemodynamic and safety outcomes, while the first-ever results from the investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results